Earlier this week we broke the 400 000 euro investment round that Valkee managed to close from some of the top tier angels around. Talouselämä, a Finnish weekly publication, has stated that the investment event that took place this week into Valkee has valued the company at 4 million euros. Esther Dyson, Anssi Vanjoki, Jyri Engeström and Lifeline Ventures received 10% of the company for their 400 000 euro investment. In total, there were six individuals and organisations who invested into the company.
Talouselämä covers each week the acquisitions and stock emissions that have taken place in Finland (that are disclosed to them) and did so with Valkee as well. The publication lists the above four investors and two unknown private equity investors as well. The same story states that Valkee is closer to 1 million euros in revenue this year and also employs some 20 people in total.
Our last story got an interesting discussion going on and the whole story attracted some 30 comments. Despite the large amount of comments, the discussion was had between few parties only. The story drew some skeptics into wondering if Valkee really has medical studies to back their product marketing. A submission to further study the case has been submitted to Valvira (The Finnish National Supervisory Authority for Welfare and Health). It remains to be seen what the outcome for the analysis is.
Update (17th December @ 2PM GMT): According to this tweet by Timo Ahopelto, one of the partners behind Lifeline Ventures, Valkee is also looking for smart people to work with them to expand the sales network to Europe.